{"doi":"10.1089/aid.1988.4.381","title":"Cell-Specific Activity of the Human Immunodeficiency Virus Enhancer Repeat In Vitro","abstract":"<jats:p>The binding of nuclear proteins and the functional activity of the HIV-LTR enhancer repeats in different cell lines (Jurkat, CEM, H9, U937, Raji, B cells, T47D, HeLa, 293, and HepG2 cells) was investigated in vitro. Five distinct complexes formed with the enhancer repeat have been identified by an electrophoretic mobility shift assay. The distribution of these complexes varied qualitatively and quantitatively between nuclear proteins from different sources. In the extracts tested, transcription of the HIV-LTR 5′ deletion mutants (-453/80, -176/80, -117/80, -103/80, -65/80, and -48/80) was initiated correctly. Transcriptional stimulation dependent upon the presence of the enhancer repeat sequences was observed in all nuclear extracts and was highest in Jurkat, Raji, and B cell extracts. The presence of specific factors and the functional activity of the enhancer repeats as well as other regulatory units in a variety of cells indicates limited host-cell restriction of HIV transcription initiation in vitro.</jats:p>","journal":"AIDS Research and Human Retroviruses","year":1988,"id":601419,"datarank":0.4335557636844247,"base_score":2.8903717578961645,"endowment":2.8903717578961645,"self_citation_contribution":0.4335557636844247,"citation_network_contribution":0.0,"self_endowment_contribution":0.4335557636844247,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":17,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":6364,"name":"Peter Ghazal","orcid":"0000-0003-0035-2228","position":1,"is_corresponding":false},{"id":444094,"name":"Jay A. Nelson","orcid":"0000-0002-5374-9133","position":2,"is_corresponding":false},{"id":14888,"name":"Lothar Hennighausen","orcid":"0000-0001-8319-9841","position":3,"is_corresponding":false},{"id":1542126,"name":"Henryk Lubon","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Cell-Specific Activity of the Human Immunodeficiency Virus Enhancer Repeat In Vitro","abstract":"<jats:p>The binding of nuclear proteins and the functional activity of the HIV-LTR enhancer repeats in different cell lines (Jurkat, CEM, H9, U937, Raji, B cells, T47D, HeLa, 293, and HepG2 cells) was investigated in vitro. Five distinct complexes formed with the enhancer repeat have been identified by an electrophoretic mobility shift assay. The distribution of these complexes varied qualitatively and quantitatively between nuclear proteins from different sources. In the extracts tested, transcription of the HIV-LTR 5′ deletion mutants (-453/80, -176/80, -117/80, -103/80, -65/80, and -48/80) was initiated correctly. Transcriptional stimulation dependent upon the presence of the enhancer repeat sequences was observed in all nuclear extracts and was highest in Jurkat, Raji, and B cell extracts. The presence of specific factors and the functional activity of the enhancer repeats as well as other regulatory units in a variety of cells indicates limited host-cell restriction of HIV transcription initiation in vitro.</jats:p>","is_dataset_classified":null,"base_score":2.8903717578961645,"endowment":2.8903717578961645,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"2848558","pmcid":null,"openalex_id":"https://openalex.org/W2053390380","authors":[],"funders":[],"total_grants":0,"fwci":0.659,"citation_percentile":0.7161066,"influential_citations":0,"citation_trend":[],"oa_status":"closed","license":"https://journals.sagepub.com/page/policies/text-and-data-mining-license","oa_locations":[{"url":"https://journals.sagepub.com/doi/pdf/10.1089/aid.1988.4.381","host_type":"publisher"},{"url":"https://doi.org/10.1089/aid.1988.4.381","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/2848558","host_type":"repository"},{"url":"https://orca.cardiff.ac.uk/114067/","host_type":"repository"}],"fields_of_study":["HIV Research and Treatment","HIV/AIDS drug development and treatment","RNA Interference and Gene Delivery"],"mesh_terms":["Cell Line","Cytomegalovirus","DNA, Viral","Enhancer Elements, Genetic","HIV","Humans","Mutation","Nuclear Proteins","Promoter Regions, Genetic","Protein Binding","Repetitive Sequences, Nucleic Acid","Transcription, Genetic"],"keywords":["Jurkat cells","Enhancer","Raji cell","Biology","HeLa","Molecular biology","Electrophoretic mobility shift assay","In vitro","Enhancer RNAs","Transcription (linguistics)","Long terminal repeat","HIV Long Terminal Repeat","Cell","Cell culture","Transcription factor","Gene expression","Gene","T cell","Genetics"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-29T16:17:42.704380Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}